← back to search

Elliot Kang

University of California, Los Angeles · US
Area of research
Oncology · Education
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Online and Blended Learning, Urban Transport and Accessibility, and Thyroid Cancer Diagnosis and Treatment.
h-index
4
citations
136
works
9
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Cell 2025cited by 52position: middledoi
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Organoids 2022cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yan-Ruide Li · University of California, Los Angeles2 papers (2022–2025)Yichen Zhu · University of California, Los Angeles2 papers (2022–2025)Taylor Basso · Scripps Research Institute1 papers (2022–2022)Yanqi Yu · University of California, Los Angeles1 papers (2022–2022)Evelynn Chen · University of California, Los Angeles1 papers (2022–2022)Audrey Fung · University of California, Los Angeles1 papers (2025–2025)Jin Zhou · University of Miami1 papers (2025–2025)Zhe Li · Ningbo University1 papers (2025–2025)Bo Li · University of California, Los Angeles1 papers (2025–2025)Jie Huang · Nanjing Medical University1 papers (2025–2025)Yuning Chen · Shanghai Medical College of Fudan University1 papers (2025–2025)Quentin Scarborough · University of California, Los Angeles1 papers (2025–2025)Robin Cadd · University of California, Los Angeles1 papers (2025–2025)James Elsten-Brown · University of California, Los Angeles1 papers (2025–2025)Feiyang Ma · Shihezi University1 papers (2025–2025)Matthew Wilson · Beatson West of Scotland Cancer Centre1 papers (2022–2022)Matteo Pellegrini · University of California, Los Angeles1 papers (2025–2025)Arnold I. Chin · University of California, Los Angeles1 papers (2025–2025)Miao Li · Union Hospital1 papers (2025–2025)Lili Yang · Shandong University1 papers (2025–2025)